4° AMIB-ESICM SYMPOSIUM

4° AMIB-ESICM SYMPOSIUM

  • 17 Alunos matriculados
  • 26 Horas de duração
  • 72 Aulas
  • 4 Módulos
  • 1 ano de suporte
  • Certificado de conclusão
Parcele em 10x R$ 100,00 (ou R$ 1.000,00 à vista)
Comprar Agora Dê um passo adiante em sua carreira!
Medicine Cursos

Um dos mais tradicionais Simpósios da AMIB em parceria com a Sociedade Européia de Medicina Intensiva chega a sua 4ª edição trazendo muitas novidades!

E apenas os clientes da Medicine terão acesso exclusivo a todo o conteúdo nacional e internacional.

2 anos Sem tempo para fazer o curso agora? Não tem problema.
Você poderá participar desse curso até 2 anos após a matrícula.

TERAPIA INTENSIVA / EMERGENCISTA / SEPSE 

Medicine Cursos
""


Certificado de horas de atualização*. 

* Não válido como participação do evento, bem como a pontuação do CNA

* Certificado concedido a mais de 70% de audiência das aulas.

Conteúdo Programático

  • 1. HEART-LUNG INTERACTIONS
  • 2. CVP and PAOP: WHAT ARE THEY USEFUL FOR?
  • 3. DISCUSSÃO
  • 4. LEFT AND RIGHT HEART EVALUATION HAEMODYNAMICS
  • 5. HEART-LUNG INTERACTIONS
  • 6. DISCUSSÃO
  • 7. HEMODYNAMIC MONITORING CASE PRESENTATION
  • 8. WE SHOULD USE ECHOCARDIOGRAPHY!
  • 9. WE SHOULD USE MINIMALLY INVASIVE DEVICES?
  • 10. THERE IS STILL A ROLE FOR PAC
  • 11. CASO CLÍNICO
  • 12. NEW VASOPRESSORS
  • 13. NEW INOTROPES
  • 14. MONITORING THE MICROCIRCULATON IN SHOCK STATES
  • 15. FLUID RESPONSIVENESS WHAT HAVE WE LEARNT OVER THE PAST 20 YEARS?
  • 16. CLINICAL ASSESSMENT
  • 17. CYBORGS IN THE ICU OF THE FUTURE: ECMO
  • 18. PROTECTING THE LUNGS DURING ASSISTED VENTILATION
  • 19. SIMULAÇÃO
  • 1. EXTRACORPOREAL LUNG SUPPORT: AN INTEGRATED VIEW
  • 2. CLINICAL USE OF ECCO2R IN ARDS
  • 3. NON TRADITION AL MODES OF VENTILATION: CLOSED LOOPS, APRV AND NOISY VENTILATION
  • 4. VENTILATOR SETTINGS DURING EXTRACORPOREAL LIFE SUPPORT
  • 5. CASE PRESENTATION ECMO
  • 6. DIAGNOSIS AND MANAGEMENT OF VENTILATOR-INDUCED DIAPHRAGMATIC DYSFUNCTION (VIDD)
  • 7. LUNG ULTRASSOUND AND EIT IN THE MANAGEMENT OF RESPIRATORY FAILURE
  • 8. TARGET OF OXYGENATION OF MECHANICAL VENTILATION IN CRITICALLY ILL PATIENTS
  • 9. CASO CLÍNICO INSUF RESPIRATÓRIA HIPOXÊMICA
  • 10. HOW TO ACHIEVE BETTER RESULTS IN RCT OF MECHANICAL VENTILATION
  • 11. TOWARDS PRECISION MEDICINE THE USE OF SUBPHENOTYPES TO DELIVER THE BEST TREATMENT
  • 12. CRITICAL REVIEW OF THE USE OF ESOPHAGEAL PRESSURE
  • 13. THE IMPORTANCE OF ASYNCHRONY DURING MECHANICAL VENTILATION
  • 14. HOW TO PREDICIT WEANING FAILURE?
  • 15. WHAT´S THE FUTURE OF THE WEANING?
  • 16. DISCUSSÃO
  • 1. ARTERIOVENTRICULAR COUPLING
  • 2. THE SCIENCE OF RAISING THE LEGS
  • 3. TIDAL VOLUME TEST DURING PULSE PRESSURE VARIATION MEASUREMENT
  • 4. DIFFERENT DOSES OF FLUIDS FOR A FLUID CHALLENGE: IMPACT ON RESPONSE
  • 5. HEMODYNAMIC MONITORING IN COPD AND CHF PATIENTS
  • 6. HEMODYNAMIC EFFECTS OF PRONE POSITION
  • 7. HOW TO ASSESS FLUID RESPONSIVENESS IN THE SURGICAL PATIENT
  • 8. CASE PRESENTATION
  • 9. SECOND VASOPRESSOR: EPINEPHRINE OR VASOPRESSIN OR?
  • 10. METHYLENE BLUE, GIK, THIAMINE, VIT. C AND OTHER “MAGIC POTIONS”?
  • 11. AND NOW, WHAT SHOULD WE DO WITH CORTICOSTEROIDS?
  • 12. ENCONTRO COM ESPECIALISTAS
  • 13. LACTATE: ONLY A MARKER OF TISSUE HYPOPERFUSION?
  • 14. WHAT DOES HIGH PERSISTENT SCVO2 MEAN?
  • 15. SHOULD WE USE BETA-BLOCKERS FOR SEPTIC SHOCK?
  • 16. DOES THE INFUSION SPEED MATTERS?
  • 17. FIXED VOLUME RESUSCITATION FOR SEPSIS: REALLY?
  • 18. SHOULD WE ABANDON NORMAL SALINE NOW?
  • 19. EIT ACTIVITIES IN EXPERIMENTAL MODEL
  • 1. HOW VENTILATORS INJURE LUNGS?
  • 2. IMPLICATIONS OF VILI BEYOND ARDS
  • 3. MECHANICAL POWER: CLINICAL UTILITY?
  • 4. HOW THE VENTILATOR CURVES CAN HELP ME?
  • 5. E QUANDO A GASOMETRIA ARTERIAL NÃO ESTA DISPONÍVEL?
  • 6. RV DYSFUNCTION AND HIGHER PEEP LEVELS
  • 7. NEW INSIGHTS HEART-LUNG INTERACTIONS DURING PROTECTIVE VENTILATION
  • 8. CASOS CLÍNICOS
  • 9. MONITORAÇÃO HEMODINÂMICA AVANÇADA VENTILAÇÃO MECÂNICA
  • 10. USE OF NONINVASIVE VENTILATION OR HFNC IN THE PALLIATIVE CARE
  • 11. HOW TO MONITOR THE PATIENT UNDER NON-INVASIVE SUPPORT?
  • 12. PERGUNTAS
  • 13. AND AFTER MECHANICAL VENTILATION?
  • 14. CORTICOSTEROID THERAPY IN ARDS
  • 15. THE BEST MOMENT FOR THE TRACHEOSTOMY
  • 16. STEM CELL THERAPY IN PATIENTS WITH ARDS: THE FUTURE?
  • 17. CERTEZAS E INCERTEZAS VM POSIÇÃO PRONA x RECRUTAMENTO ALVEOLAR
  • 18. THE INADVERTENT RISKS OF ASSISTING SPONTANEOUS BREATHING
Voltar ao topo